4th International Congress on Sickle Cell and Other Inherited Blood Disorders

The GANSID Congress 2026 is a global gathering, bringing together clinicians, researchers, laboratory and/or translational scientists, patient organizations, industry partners, policymakers and global health agencies.

Building on the success of previous virtual congresses, the GANSID Congress 2026 is the 1st in-person Congress of the GANSID, offering a unique cross-disease platform focused on inherited blood disorders.

The 2026 Congress will focus on key scientific and health system priorities, including:

• Emerging therapies and curative approaches, including gene and cellular therapies.
• Advances in transfusion medicine and comprehensive care.
• Implementation science and health system integration in low- and middle-income countries.
• Patient-centred outcomes, quality of life, and community engagement.

Registration

Please note: A registration fee is required for this event. For additional details about the event and registration, including an online registration form, visit Congress – Inherited Blood Disorders